Xblkbk, Excellent point (As usual.) If I might add that Covid-19 is adding to the Cardiovascular Disease burden and Vascepa may be part of the solution to that problem, unlikely unless the Marine patents are restored. Of course, Marjac has very limited time and must respond directly to the judges questions clearly and concisely. (I guess that means he may select one sentence sound bites and avoid lectures.) I am confident he will do his best.
xbl, "caused Amarin to stop advertising and gut its sales force!!"? Please don't mention it, otherwise, the panel would blame Amarin for stopping advertising and gutting its workforce and causing more CVD death. To the panel, GV is just as effective as V but cheaper.
Market Data 
Markets 
AI
